Elevated coated-platelets in symptomatic large-artery stenosis patients are associated with early stroke recurrence

References

• Dale GL. Coated-platelets: An emerging component of the procoagulant response. J Thromb Haemostasis 2005; 3: 2185–2192
   PubMed Web of Science ®Google Scholar
• Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen and convulxin. Blood 2000; 95: 1694–1702
   PubMed Web of Science ®Google Scholar
• Dale GL, Remenyi G, Friese P. Quantitation of microparticles released from coated-platelets. J Thromb Haemostasis 2005; 3: 2081–2088
   PubMed Web of Science ®Google Scholar
• Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415: 175–179
   PubMed Web of Science ®Google Scholar
• Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscl Thromb Vasc Biol 2005; 25: 467–471
   PubMed Web of Science ®Google Scholar
• Prodan CI, Joseph PM, Vincent AS, Dale GL. Coated-platelets in ischemic stroke: Differences between lacunar and cortical stroke. J Thromb Haemostasis 2008; 6: 609–614
   PubMed Web of Science ®Google Scholar
• Prodan CI, Stoner JA, Cowan LD, Dale GL. Lower coated-platelet levels are associated with early hemorrhagic transformation in patients with non-lacunar brain infarction. J Thromb Haemostasis 2010; 8: 1185–1190
   PubMed Web of Science ®Google Scholar
• Prodan CI, Vincent AS, Padmanabhan R, Dale GL. Coated-platelet levels are low in patients with spontaneous intracerebral hemorrhage. Stroke 2009; 40: 2578–2580
   PubMedGoogle Scholar
• Prodan CI, Vincent AS, Dale GL. Coated platelet levels correlate with bleed volume in patients with spontaneous intracerebral hemorrhage. Stroke 2010; 41: 1301–1303
   PubMed Web of Science ®Google Scholar
• Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62: 569–573
   PubMed Web of Science ®Google Scholar
• Marquardt L, Kuker W, Chandratheva A, Geraghty O, Rothwell PM. Incidence and prognosis of >or =50% symptomatic vertebral or basilar artery stenosis: Prospective population-based study. Brain 2009; 132: 982–988
   PubMed Web of Science ®Google Scholar
• Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, et al. A/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients with Extracranial Carotid and Vertebral Artery Disease: Executive Summary a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2011;57:1002–1044
   Google Scholar
• North American Symptomatic Carotid Endarterectomy Trialist's Collaborative Group. The final results of the NASCET Trial. N Engl J Med 1998; 339: 1415–1425
   PubMedGoogle Scholar
• Prodan CI, Ross ED, Stoner JA, Cowan LD, Vincent AS, Dale GL. Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology 2011; 76: 247–252
   PubMed Web of Science ®Google Scholar
• Coull AJ, Rothwell PM. Underestimation of the early risk of recurrent stroke: Evidence of the need for a standard definition. Stroke 2004; 35: 1925–1929
   PubMed Web of Science ®Google Scholar
• Jenkins AJ, Gosmanova AK, Lyons TJ, May KD, Dashti A, Baker MZ, Olansky L, Aston CE, Dale GL. Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus. Diabetes Res Clin Pract 2008; 81: e8–10
   PubMed Web of Science ®Google Scholar
• Valaydon ZS, Lee P, Dale GL, et al. Increased coated-platelet levels in chronic haemodialysis patients. Nephrology (Carlton) 2009; 14: 148–154
   PubMedGoogle Scholar
• Prodan CI, Vincent AS, Dale GL, Higher coated-platelet levels are associated with chronic hypertension in patients with transient ischemic attack. Platelets 2012 (in press, doi: 10.3109/09537104.2012.696747; PMID: 22720775)
   Google Scholar
• Norgard NB, Saya S, Hann CL, Hennebry TA, Schechter E, Dale GL. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization. J Cardiovasc Pharmacol 2008; 52: 536–539
   PubMed Web of Science ®Google Scholar
• Prodan CI, Joseph PM, Vincent AS, Dale GL. Coated-platelet levels are influenced by smoking, aspirin and selective serotonin reuptake inhibitors. J Thromb Haemostasis 2007; 5: 2149–2151
   PubMed Web of Science ®Google Scholar
• Prodan CI, Vincent AS, Dale GL. Coated-platelet levels are elevated in patients with transient ischemic attack. Transl Res 2011; 158: 71–75
   PubMed Web of Science ®Google Scholar
• Smith NM, Pathansali R, Bath PM. Platelets and stroke. Vasc Med 1999; 4: 165–172
   PubMed Web of Science ®Google Scholar
• Brooks MB, Catalfamo JL, Friese P, Dale GL. Scott syndrome dogs have impaired coated-platelet formation and calcein release but normal mitochondrial depolarization. J Thromb Haemostasis 2007; 5: 1972–1974
   PubMed Web of Science ®Google Scholar
• Brooks MB, Catalfamo JL, Brown HA, Ivanova P, Lovaglio J. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood 2002; 99: 2434–2441
   PubMedGoogle Scholar
• Brooks MB, Randolph J, Warner K, Center S. Evaluation of platelet function screening tests to detect platelet procoagulant deficiency in dogs with Scott syndrome. Vet Clin Pathol 2009; 38: 306–315
   PubMedGoogle Scholar